Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study (Q43973627)
Jump to navigation
Jump to search
scientific article published on 11 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study |
scientific article published on 11 June 2013 |
Statements
1 reference
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study (English)
1 reference
Tjalf Ziemssen
1 reference
Hans-Peter Hartung
1 reference
Olaf Stüve
1 reference
Ludwig Kappos
1 reference
Krzysztof Selmaj
1 reference
Lixin Zhang Auberson
1 reference
Xavier Montalban
1 reference
Frank Dahlke
1 reference
Mark S Freedman
1 reference
Bernhard Hemmer
1 reference
Peter Rieckmann
1 reference
Erik Wallström
1 reference
David K B Li
1 reference
Harald Pohlmann
1 reference
Francois Mercier
1 reference
11 June 2013
1 reference
1 reference
12
1 reference
8
1 reference
756-767
1 reference
Identifiers
1 reference
1 reference